外泌体研究产品市场规模、份额和成长分析（按产品、适应症、应用、製造服务、最终用户和地区）- 产业预测，2025-2032 年

全球外泌体研究产品市场规模预计将在 2023 年达到 1.5579 亿美元，从 2024 年的 1.8056 亿美元增长到 2032 年的 5.8788 亿美元，预测期内（2025-2032 年）的复合年增长率为 15.9%。

由于学术研究机构、製药和生物技术公司、医院和临床试验的兴趣日益浓厚，外泌体研究产品市场正在经历显着增长。外泌体研究需求的激增是由其诊断潜力和作为细胞间通讯者的新兴角色所推动的。截至 2022 年，全球有超过 6,000 种物质正在接受临床试验测试，医药品研究开发费用成长惊人，达到 68%，市场势头强劲。世界卫生组织 (WHO) 强调，癌症相关死亡人数呈现惊人成长，到 2020 年将达到近 1,000 万人，促使研究人员寻找用于癌症检测的生物标记。再加上心血管疾病和类风湿性关节炎等慢性病发病率的上升，对药品的需求可能在未来几年推动外泌体研究产品市场的进一步成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 宏观经济指标
• 价值链分析
• 定价分析

外泌体研究产品市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 套件和试剂
  • 抗体
  • 分离精製定量套件试剂
  • 其他套件和试剂
• 装置
• 服务

外泌体研究产品市场规模（按适应症和复合年增长率） (2025-2032)

• 市场概况
• 癌症适应症
  • 肺癌
  • 乳癌
  • 摄护腺癌
  • 大肠直肠癌
  • 其他癌症
• 神经退化性疾病
• 心血管疾病
• 感染疾病
• 其他疾病

外泌体研究产品市场规模（按应用和复合年增长率） (2025-2032)

• 市场概况
• 生物标誌物
• 疫苗研发
• 组织再生
• 其他用途

外泌体研究产品市场规模依製造服务及复合年增长率 (2025-2032)

• 市场概况
• 干细胞来源的外泌体製造服务
• 树突细胞来源的外泌体製造服务
• 其他製造服务

外泌体研究产品市场规模（依最终用户和复合年增长率） (2025-2032)

• 市场概况
• 学术研究所
• 製药和生物技术公司
• 医院和临床实验室

外泌体研究产品市场规模（按地区和复合年增长率） (2025-2032)

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific Inc.（United States）
• QIAGEN NV（Germany）
• Lonza Group Ltd.（Switzerland）
• Miltenyi Biotec（Germany）
• Key Developments
• Danaher Corporation（United States）
• Hologic Inc.（United States）
• Fujifilm Holdings Corporation（Japan）
• Hitachi Chemical Diagnostics Inc.（Japan）
• MBL International（United States）
• Novus Biologicals（United States）
• System Biosciences（SBI）（United States）
• NanoSomix Inc.（United States）
• Norgen Biotek Corp.（Canada）
• AMS Biotechnology（Europe）Limited（United Kingdom）
• Aethlon Medical Inc.（United States）
• Capricor Therapeutics Inc.（United States）
• Creative Medical Technology Holdings Inc.（United States）
• Evox Therapeutics Ltd.（United Kingdom）

结论和建议

Global Exosome Research Products Market size was valued at USD 155.79 million in 2023 and is poised to grow from USD 180.56 million in 2024 to USD 587.88 million by 2032, growing at a CAGR of 15.9% during the forecast period (2025-2032).

The exosome research products market is witnessing significant growth driven by heightened interest from academic research institutes, pharmaceutical and biotechnology companies, hospitals, and clinical trials. The surge in demand for exosome studies stems from their diagnostic potential and emerging role as intercellular communicators. With over 6,000 substances tested globally in clinical trials-an impressive 68% rise in pharmaceutical R&D spending as of 2022-the market's momentum is strong. The World Health Organization has highlighted the alarming rise in cancer-related deaths, with nearly 10 million in 2020, further pressing researchers to identify biomarkers for cancer detection. Coupled with the rising incidence of chronic diseases, including cardiovascular issues and rheumatoid arthritis, the demand for pharmaceutical drugs is set to propel further growth in the exosome research products market in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Exosome Research Products market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Exosome Research Products Market Segments Analysis

Global Exosome Research Products Market is segmented by Product, Indication, Application, Manufacturing Service, End User and Region. Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Indication, the market is segmented into Cancer Indication, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases and Other Diseases. Based on Application, the market is segmented into Biomarkers, Vaccine Development, Tissue Regeneration and Other applications. Based on Manufacturing Service, the market is segmented into Stem cell-derived exosome manufacturing services, Dendritic cell-derived exosome manufacturing services and Other manufacturing services. Based on End User, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies and Hospitals & Clinical Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Exosome Research Products Market

The growing recognition of exosomes as crucial components in intercellular communication, biomarker identification, and understanding disease mechanisms is significantly boosting interest in exosome-related products. Researchers are delving into the versatile applications of exosomes for diagnostics, therapeutic solutions, and drug delivery systems. This heightened focus on the potential of exosomes as valuable tools in various biomedical fields is driving an increasing demand for research products specifically designed for exosome studies. As the significance of exosomes continues to be acknowledged, the global market for exosome research products is set to expand, reflecting the ongoing advancements in scientific exploration and innovation.

Restraints in the Global Exosome Research Products Market

The Global Exosome Research Products market faces significant challenges due to the substantial heterogeneity of exosomes in terms of their size, composition, and cargo. This variability complicates their isolation, characterization, and functional analysis. Furthermore, the intricate nature of exosome biology, combined with the absence of standardized protocols, can hinder reproducibility and complicate data interpretation in exosome studies. These factors collectively present obstacles for researchers, impacting their ability to draw consistent and reliable conclusions, thus restraining progress in the field and potentially limiting market growth for exosome research products.

Market Trends of the Global Exosome Research Products Market

The global exosome research products market is witnessing a significant trend towards the adoption of advanced isolation and analytical technologies. Researchers are increasingly focused on developing sophisticated methods to isolate exosomes from complex biological samples, such as blood, urine, and tissue fluids, ensuring high purity and yield. This trend is driven by a rising demand for integrated systems that facilitate comprehensive characterization and functional analysis of exosomes, encompassing their delivery molecules, surface markers, and biological activities. As the scientific community strives for more precision in exosome research, the market is expected to expand, fostering innovation and enhancing product offerings.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Exosome Research Products Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Kits & Reagents
  • Antibodies
  • Isolation, Purification, Quantitation Kits, and reagents
  • Other kits & reagents
• Instruments
• Services

Global Exosome Research Products Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Cancer Indication
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Other Cancers
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Infectious Diseases
• Other Diseases

Global Exosome Research Products Market Size by Application & CAGR (2025-2032)

• Market Overview
• Biomarkers
• Vaccine Development
• Tissue Regeneration
• Other applications

Global Exosome Research Products Market Size by Manufacturing Service & CAGR (2025-2032)

• Market Overview
• Stem cell-derived exosome manufacturing services
• Dendritic cell-derived exosome manufacturing services
• Other manufacturing services

Global Exosome Research Products Market Size by End User & CAGR (2025-2032)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinical Laboratories

Global Exosome Research Products Market Size & CAGR (2025-2032)

• North America (Product & Service, Indication, Application, Manufacturing Service, End User)
  • US
  • Canada
• Europe (Product & Service, Indication, Application, Manufacturing Service, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Indication, Application, Manufacturing Service, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Indication, Application, Manufacturing Service, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Indication, Application, Manufacturing Service, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi Chemical Diagnostics Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MBL International (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novus Biologicals (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• System Biosciences (SBI) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoSomix Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norgen Biotek Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AMS Biotechnology (Europe) Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aethlon Medical Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Capricor Therapeutics Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Medical Technology Holdings Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evox Therapeutics Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations